DRKS00026128已完成不适用
Real world extension study in patients with atopic dermatitis who participated in previous tralokinumab trials - Observational ECZTEND
EO Pharma A/S0 个研究点目标入组 63 人开始时间: 2021年10月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 63
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Adult patients eligible for treatment with tralokinumab according to the national, approved label where the decision to prescribe tralokinumab has been made prior to and independently of enrolment in the study.
- •-Signed and dated informed consent.
- •-Participated in the ECZTEND clinical trial and decision to continue tralokinumab treatment with commercially available drug.
排除标准
- •-Participation in the active treatment phase of a clinical trial.
- •-Previous enrolment in the study.
- •-Contraindications according to the label.
研究者
相似试验
已完成
不适用
Clinical observation of patients with atopic dermatitis without using topical steroidsatopic dermatitisJPRN-UMIN000015781Tsurumai Kouen Clinic200
尚未招募
Unknown
Retrospective observational study of patients with atopic dermatitis in remission with Upadacitinib.Atopic DermatitisJPRN-UMIN000054106on-Profit Organization Health Institute Research of Skin300
已完成
不适用
Evaluate changes in atopic symptoms due to natural mineral water intakeHealthy adultJPRN-UMIN000038511Japan Clinical Trial Association26
招募中
不适用
Investigating biomarkers for development of atopic dermatitis in early childhood using maternal-infant hair-related microRNAEczemaJPRN-UMIN000027834Departments of Pediatrics Juntendo University, Faculty of Medicine 3-1-3 Hongo, Bunkyo-ku TOKYO, 113-0033, JAPAN TEL +81-3-3813-3111 FAX +81-3-5800-1580500
已完成
不适用
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trialAtopic dermatitisJPRN-UMIN000041204Takashima Clinic57